Clarient, Inc. (NASDAQ:CLRT)

CAPS Rating: 4 out of 5

The Company is an advanced oncology diagnostics technology and services company. It combines innovative technologies and meaningful test results to improve outcomes of patients suffering from cancer.

Recs

0
Player Avatar Stonesolidpicks (21.14) Submitted: 12/4/2009 5:53:37 PM : Outperform Start Price: $2.49 CLRT Score: +81.30

Oversold

Featured Broker Partners


Advertisement